Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clin...

por H. Brandt-Jacobsen, Niels, Johansen, Marie Louise, Rasmussen, Jon J., Dalsgaard, Morten, Kumler, Thomas, Faber, Jens, Rossignol, Patrick, Schou, Morten, Kistorp, Caroline
Publicado 2023

ODP154 Reduction of Cardiac Adipose Tissue Volume with Short-Term Empagliflozin in Patients with Type 2 Diabetes: Results from the SIMPLE Randomized Clinical Trial

por Brandt-Jacobsen, Niels, Jürgens, Mikkel, Hasbak, Phillip, Gæde, Peter, Rossing, Peter, Rasmussen, Jon, Andersen, Camillla Fuchs, Forman, Julie, Faber, Jens, Inzucchi, Silvio, Gustafsson, Finn, Schou, Morten, Kistorp, Caroline
Publicado 2022

Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial

por Jürgens, Mikkel, Schou, Morten, Hasbak, Philip, Kjær, Andreas, Wolsk, Emil, Zerahn, Bo, Wiberg, Mikkel, Brandt‐Jacobsen, Niels H., Gæde, Peter, Rossing, Peter, Faber, Jens, Inzucchi, Silvio E., Gustafsson, Finn, Kistorp, Caroline
Publicado 2021

Reduction of cardiac adipose tissue volume with short‐term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial

por Brandt‐Jacobsen, Niels H., Jürgens, Mikkel, Hasbak, Philip, Gæde, Peter, Rossing, Peter, Rasmussen, Jon J., Andersen, Camillla Fuchs, Forman, Julie L., Faber, Jens, Inzucchi, Silvio E., Gustafsson, Finn, Schou, Morten, Kistorp, Caroline
Publicado 2023